Tacrolimus and Interstitial lung diseaseThis is a study of Interstitial lung disease among people who take Tacrolimus. The study analyzes: the time on Tacrolimus when people have Interstitial lung disease, gender and age of these people, the severity of Interstitial lung disease, how they recovered, and common conditions and drugs used besides Tacrolimus. In total 12,090 Tacrolimus users are studied. The study is created by eHealthMe based on reports from FDA and is updated regularly.
Do you have chronic disease and take multiple drugs? eHealthMe can monitor your drugs and notify you when there are serious drug reactions detected. Our original studies have been used on premier medical publications. The monitor will be personalized to your gender and age. Start now TacrolimusTacrolimus has active ingredients of tacrolimus. It is used in kidney transplant, liver transplant, kidney transplant rejection, transplant, transplant rejection. Commonly reported side effects of Tacrolimus include fever, diarrhea, pneumonia, sepsis, transplant rejection. Interstitial lung diseaseInterstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, lung cancer - non-small cell, prostate cancer, osteoporosis. On May, 2, 2013: 12,090 people reported to have side effects when taking Tacrolimus. Among them, 168 people (1.39%) have Interstitial Lung Disease.  Time on Tacrolimus when people have Interstitial lung disease * :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years |
| Interstitial lung disease | 40.23% | 37.93% | 9.20% | 10.34% | 2.30% | 0.00% | 0.00% |
Gender of people who have Interstitial lung disease when taking Tacrolimus * :
| Female | Male |
| Interstitial lung disease | 50.29% | 49.71% |
Age of people who have Interstitial lung disease when taking Tacrolimus * :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ |
| Interstitial lung disease | 0.62% | 6.83% | 8.70% | 6.83% | 5.59% | 4.35% | 13.66% | 53.42% |
Severity of Interstitial lung disease when taking Tacrolimus ** :
How people recovered from Interstitial lung disease ** :
Top conditions involved for these people * :- Rheumatoid arthritis (73 people, 43.45%)
- Prophylaxis against graft versus host disease (44 people, 26.19%)
- Prophylaxis (30 people, 17.86%)
- Bone marrow conditioning regimen (29 people, 17.26%)
- Infection prophylaxis (24 people, 14.29%)
Login or sign up (it's free) to view more results. Top co-used drugs for these people * :- Prednisolone (86 people, 51.19%)
- Methotrexate (42 people, 25.00%)
- Thymoglobulin (33 people, 19.64%)
- Fludarabine phosphate (33 people, 19.64%)
- Humira (29 people, 17.26%)
Login or sign up (it's free) to view more results. * Approximation only. Some reports may have incomplete information. ** Reports from social media are used. How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood. Next: check whether interstitial lung disease is from a drug or a condition You can also:
On eHealthMe, Tacrolimus (tacrolimus) is often used for kidney transplant. Find out below the conditions Tacrolimus is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions. What is Tacrolimus used for and how effective is it: Other drugs that are used to treat the same conditions: Could it be a symptom from a condition: Browse Tacrolimus side effects from A to Z:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z Browse Tacrolimus drug interactions with drugs from A to Z:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z Drugs in real world that are associated with: Comments from related studies: From this study (2 weeks ago): zarlay on May, 8, 2013: My patient is 71year old man, asian, been on phenytoin for 18 years, and crackles were detected on both lungs on routine examination, without any symptom. HRCT show diffused interstial lung disease. I would like to know treatment on this pstient after withdrawl of phenytoin. Reply From this study (3 weeks ago): i have kidney transpjantation in 27 march 2013 now iam on above mentioned drugs and i have severe bodyaches monocytosis ang leukopenia tacrolimuf level is 11 now Reply Louis on May, 2, 2013: Prograf is a good drug, Its only real know issue is that it can cause kidney problems in patents that have had issues with both kidneys. Its currently one of the top three. Some people do experience issues with it at high dosage after transplant when the keep your immune system almost shut off. After a few months they will gradually decrease. I am 8 months out after a liver transplant. Original dosage was 17 mg twice a day, Not I am on 1 mg twice a day. Along with Celcept originally 1gm twice a day now 500 mg twice a day. I have body aches all the time. It was worse after the transplant. Remember that they just ripped apart you internal organs. Reply From this study (2 months ago): After one year of kidney transplantation...I now have breast cancer....and is diagnose with, Invassive Ductal Carcinoma. I believe I developed this due to the immunosuppressant drugs I take to avoid kidney reject.... Reply Zelna on Apr, 11, 2013: I'm a 38 year old female had a kidney transplant in 2003 is also diagnosed in 2012 with addisons disease, breast cancer, Invassive Ductal Carcinoma, and blood disorder, normal platelet count but abnormal functioning of it blood not clotting. Using prednisone 5 mg, hydrocotisone 10 mg, prograf, imuran 125 mg Reply From this study (2 months ago): Wanting to know effects of chemo on antirejection drug Reply
Post a new comment OR Read more comments Recent related drug checks on eHealthMe:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent drug studies on eHealthMe:
|
|